Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Covington
Deloitte
McKesson
Queensland Health
UBS
Fish and Richardson
Harvard Business School
Johnson and Johnson

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022009

« Back to Dashboard

NDA 022009 describes ANTHELIOS 40, which is a drug marketed by Loreal Usa and is included in one NDA. Additional details are available on the ANTHELIOS 40 profile page.

The generic ingredient in ANTHELIOS 40 is avobenzone; ecamsule; octocrylene; titanium dioxide. There are two drug master file entries for this compound. Additional details are available on the avobenzone; ecamsule; octocrylene; titanium dioxide profile page.
Summary for 022009
Tradename:ANTHELIOS 40
Applicant:Loreal Usa
Ingredient:avobenzone; ecamsule; octocrylene; titanium dioxide
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:CREAM;TOPICALStrength2%;3%;10%;5%
Approval Date:Mar 31, 2008TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:CREAM;TOPICALStrength2%;3%;10%;5%
Approval Date:Oct 29, 2009TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Express Scripts
Baxter
US Army
AstraZeneca
Johnson and Johnson
UBS
Farmers Insurance
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.